Admission Hyperglycemia and Adverse Outcomes in Diabetic and Non-Diabetic Patients with Non-St-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Yuanyuan Hao,Qun Lu,Tao Li,Guodong Yang,Peijing Hu,Aiqun Ma
DOI: https://doi.org/10.1186/s12872-016-0441-x
IF: 2.174
2017-01-01
BMC Cardiovascular Disorders
Abstract:The association between admission hyperglycemia and adverse outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI) has not been well studied, and the optimal plasma glucose cut-off values for prognosis for NSTEMI patients with and without diabetes have not been determined.
What problem does this paper attempt to address?